D. Peng

Jing Wang, I. Wistuba, C. Behrens, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Targeting HER2 Exon 20 Insertion–Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib

Kwok-Kin Wong, Haiquan Chen, C. Peng, 2021, Cancer Research.

PI4KIIIβ is a therapeutic target in chromosome 1q–amplified lung adenocarcinoma

P. Brown, K. Shokat, I. Wistuba, 2020, Science Translational Medicine.

ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1 mutant lung cancer

C. Perou, C. Rudin, G. Freeman, 2021, Nature Cancer.

The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL

C. Creighton, D. Gibbons, Dong-Hoon Shin, 2016, Scientific Reports.

Exacerbation of oxidative stress-induced cell death and differentiation in induced pluripotent stem cells lacking heme oxygenase-1.

Chiu-Ying Peng, Chen-Yu Lin, S. yet, 2012, Stem cells and development.

Growth and metastasis of lung adenocarcinoma is potentiated by BMP4-mediated immunosuppression

Jing Wang, L. Byers, D. Gibbons, 2016, Oncoimmunology.

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumor cell PD-L1 expression and intratumoral immunosuppression

Lixia Diao, F. Xiao-Feng Qin, Gordon Robertson, 2014, Nature Communications.

AXL Inhibition Induces DNA Damage and Replication Stress in Non–Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors

Jing Wang, L. Byers, D. Gibbons, 2020, Molecular Cancer Research.

A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components

E. Dmitrovsky, Jing Wang, U. McDermott, 2020, Science Translational Medicine.

CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade.

E. Dmitrovsky, Jing Wang, I. Wistuba, 2018, Cancer discovery.

Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers

J. Konen, P. Gaudreau, L. Byers, 2021, Nature Communications.

Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma

Yong Hou, Shiping Liu, S. Qiu, 2021, Nature Communications.

ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism

Jing Wang, I. Wistuba, L. Byers, 2019, Science Translational Medicine.

Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer

Jing Wang, J. Minna, L. Girard, 2015, Clinical Cancer Research.

ZEB1/NuRD complex suppresses TBC1D2b to stimulate E-cadherin internalization and promote metastasis in lung cancer

C. Creighton, B. Raught, Fengju Chen, 2019, Nature Communications.

ZEB 1 sensitizes lung adenocarcinoma to metastasis suppression by PI 3 K antagonism

I. Wistuba, C. Creighton, Steven H. Lin, 2018 .

ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism.

I. Wistuba, C. Creighton, Steven H. Lin, 2014, The Journal of clinical investigation.

The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers

Jing Wang, C. Creighton, L. Byers, 2015, Oncogene.

Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLC

Jing Wang, J. Konen, L. Byers, 2021, Cancer Research.

Title : Targeting HER 2 Exon 20 Insertion-Mutant Lung Adenocarcinoma with a Novel 2 Tyrosine Kinase Inhibitor

Kwok-Kin Wong, Haiquan Chen, V. Rivera, 2021 .

In vivo metabolomics identifies CD38 as an emergent vulnerability in LKB1-mutant lung cancer

C. Rudin, H. Ji, B. Neel, 2023, bioRxiv.

Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers

Jing Wang, J. Konen, P. Gaudreau, 2020, Nature Communications.

Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance

J. Konen, D. Gibbons, L. Solis, 2023, Frontiers in Immunology.

Growth and metastasis of lung adenocarcinoma is potentiated by BMP4-mediated immunosuppression

Jing Wang, L. Byers, D. Gibbons, 2016, Oncoimmunology.